Cognitive behavioural therapy for chronic insomnia Interventions Chronic insomnia is the third most common psychological reason for GP consultations – most patients prefer not to take medication to overcome this problem
Cognitive behavioural therapy for chronic insomnia A-Z interventions and conditions Chronic insomnia is the third most common psychological reason for GP consultations – most patients prefer not to take medication to overcome this problem
Cognitive behavioural therapy for chronic insomnia Conditions Chronic insomnia is the third most common psychological reason for GP consultations – most patients prefer not to take medication to overcome this problem
Brief behavioural therapy: insomnia in adults Interventions Physical health problems are present in about one-third of patients with insomnia, defined as repeated difficulty with sleep over a period of a month
Brief behavioural therapy: insomnia in adults A-Z interventions and conditions Physical health problems are present in about one-third of patients with insomnia, defined as repeated difficulty with sleep over a period of a month
Brief behavioural therapy: insomnia in adults Conditions Physical health problems are present in about one-third of patients with insomnia, defined as repeated difficulty with sleep over a period of a month
Music for insomnia in adults Conditions German composer Max Richter released ‘Sleep’, an eight-hour ‘lullaby for a frenetic world’ and at the world premiere in London, listeners were offered beds instead of chairs
Music for insomnia in adults A-Z interventions and conditions German composer Max Richter released ‘Sleep’, an eight-hour ‘lullaby for a frenetic world’ and at the world premiere in London, listeners were offered beds instead of chairs
Exercise for cancer fatigue Interventions Cancer-related fatigue is a complex and common experience, affecting 70–100% of the cancer patient population
Exercise for cancer fatigue A-Z interventions and conditions Cancer-related fatigue is a complex and common experience, affecting 70–100% of the cancer patient population